Enrico A. Fassi

Università Degli Studi Di Milano Via L. Mangiagalli 25 20133 Milano Italy
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Structure-guided design of an LC3B-targeting PNA oligomer modulating autophagy and LC3B-mediated mRNA decay.

Structure-guided design of an LC3B-targeting PNA oligomer modulating autophagy and LC3B-mediated mRNA decay.

Journal: RSC medicinal chemistry

Published: June 19, 2026

PCSK9 inhibitors: an updated patent review 2024-2025.

PCSK9 inhibitors: an updated patent review 2024-2025.

Journal: Expert opinion on therapeutic patents

Published: May 14, 2026

A nicotinic-dopaminergic hybrid probe enhances D2-like autoreceptor-mediated inhibition of dopamine release.

A nicotinic-dopaminergic hybrid probe enhances D2-like autoreceptor-mediated inhibition of dopamine release.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 24, 2026

Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS-CoV-2 Mpro for Next-Generation PROTAC-Based Therapeutics.

Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS-CoV-2 Mpro for Next-Generation PROTAC-Based Therapeutics.

Journal: Archiv der Pharmazie

Published: July 31, 2025

Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources.

Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources.

Journal: The FEBS journal

Published: July 17, 2025

FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer.

FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer.

Journal: International journal of molecular sciences

Published: May 07, 2025

Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation.

Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation.

Journal: European journal of medicinal chemistry

Published: February 25, 2025

A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach.

A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach.

Journal: Computational and structural biotechnology journal

Published: February 24, 2025

Nature-Inspired Compounds Targeting Escherichia coli WrbA as Biofilm-Modulating Agents: Computational Design, Synthesis, and Biological Evaluation.

Nature-Inspired Compounds Targeting Escherichia coli WrbA as Biofilm-Modulating Agents: Computational Design, Synthesis, and Biological Evaluation.

Journal: Archiv der Pharmazie

Published: February 17, 2025

Novel non-peptide uracil-derived human gonadotropin-releasing hormone receptor antagonists.

Novel non-peptide uracil-derived human gonadotropin-releasing hormone receptor antagonists.

Journal: European journal of medicinal chemistry

Published: July 04, 2024

PCSK9 inhibitors: a patent review 2018-2023.

PCSK9 inhibitors: a patent review 2018-2023.

Journal: Expert opinion on therapeutic patents

Published: April 08, 2024

High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development.

High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development.

Journal: Journal of medical virology

Published: April 05, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026